1. Home
  2. DCO vs BHVN Comparison

DCO vs BHVN Comparison

Compare DCO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ducommun Incorporated

DCO

Ducommun Incorporated

HOLD

Current Price

$182.15

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.47

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCO
BHVN
Founded
1849
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
1995
2022

Fundamental Metrics

Financial Performance
Metric
DCO
BHVN
Price
$182.15
$13.47
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$153.60
$29.08
AVG Volume (30 Days)
278.1K
2.0M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.08
EPS
0.64
N/A
Revenue
$824,730,000.00
N/A
Revenue This Year
$7.40
N/A
Revenue Next Year
$8.59
N/A
P/E Ratio
$285.67
N/A
Revenue Growth
4.85
N/A
52 Week Low
$84.76
$7.48
52 Week High
$196.63
$18.57

Technical Indicators

Market Signals
Indicator
DCO
BHVN
Relative Strength Index (RSI) 57.11 43.60
Support Level $135.11 $8.25
Resistance Level $196.63 $14.01
Average True Range (ATR) 7.16 0.84
MACD 0.17 -0.31
Stochastic Oscillator 81.18 11.65

Price Performance

Historical Comparison
DCO
BHVN

About DCO Ducommun Incorporated

Ducommun Inc provides engineering & manufacturing services for high-performance products & high-cost-of failure applications used in the aerospace and defense, industrial, medical & other industries. The company's reportable segments are Structural Systems & Electronic Systems. Structural Systems designs, engineers and manufactures various sizes of complex contoured aerostructure components and assemblies and supplies composite and metal bonded structures and assemblies. Electronic Systems designs, engineers and manufactures high-reliability electronic and electromechanical products used in technology-driven markets including A&D and Industrial end-use markets. It generates maximum of its revenue from the Electronic Systems.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: